Search
Displaying 651–660 of 715 for “retinitis clinical trial”
-
At the Foundation Fighting Blindness, our employees are true beacons of hope as they are committed to our urgent mission to drive the research that will provide preventions, treatments and cures for people affected by retinitis pigmentosa, age-related macular degeneration, Usher syndrome and the entire spectrum of retinal degenerative diseases.
-
VisionWalk Home Page
-
Foundation Fighting Blindness Celebrates 15th Year of VisionWalk with New Branding
Foundation NewsThis signature fundraising event has raised more than $55 million for research leading to treatments and cures for blindness.
-
Rachel Wants to Raise White Cane Awareness
Beacon StoriesRachel Luehrs describes her journey of acceptance.
-
The Bergstein’s Are Striking Out Blindness
Fundraiser Success StoriesThe Bergstein family has always been passionate about helping the Foundation Fighting Blindness.
-
FDA Approves New Wet AMD Treatment that can be Administered Every Three Months
Research NewsBeovu from Novartis reduces treatment burden for wet AMD patients
-
Beacon Stories
Shawn was diagnosed with Usher syndrome at a young age. Shawn now stays involved with the blind community and participates in his local blind hockey league. In his own words, he shares his journey at the Toyota-USA Hockey Disabled Hockey Festival.
-
How Davida Regained Her Speed with Guide Dog Chubb
Beacon StoriesIn honor of National Guide Dog Month this September, Davida is sharing her experience with the Guide Dog Foundation for the Blind and how she found a perfect match in her new guide dog, Chubb.
-
Beacon Stories
13 year old Kailey Reichardt’s personal essay about her little sister Ashlyn, who was diagnosed with Leber congenital amarosis (LCA) at a young age. Kailey is a Beacon for other siblings impacted and going through similar situations.
-
Sustained Suppression of VEGF: Looking Forward and Looking Back
Research NewsThe results of the LADDER trial demonstrate a major step forward but introduce many questions.
